Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Enterprise value to sales ratio
3Y CAGR
-14.9%/yr
Annual compound
Percentile
P57
Within normal range
vs 3Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 7.38 | -34.4% |
| 2024 | 11.26 | -50.9% |
| 2023 | 22.94 | +91.4% |
| 2022 | 11.99 | +133.3% |
| 2021 | 5.14 | - |
| 2020 | 0.00 | - |
| 2019 | 0.00 | - |
| 2018 | 0.00 | - |